Current research suggests that viral polymerase may provide a new therapeutic target for host-adapted avian influenza. Highly pathogenic avian influenza, commonly known as bird flu, is a strain of the influenza virus that has adapted to infect birds. Although bird-specific flu strains rarely cross species, further adaption can lead to lethal infection in humans.